Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Directorate Change

1 Jul 2020 07:00

RNS Number : 5427R
Chesnara PLC
01 July 2020
 

CHESNARA plc

("Chesnara" or "the Company")

 

 

 

1 July 2020

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

NOTICE OF CHANGES TO INDEPENDENT NON EXECUTIVE DIRECTORS

 

Chesnara plc today announces that David Brand will step down from the Board with immediate effect as, after securing regulatory approval, he takes up the role as Chairman of the Company's UK business Countrywide Assured plc.

 

As a result of this change, the Company is also pleased to announce the appointment of Eamonn Flanagan as independent Non-Executive Director with immediate effect. Eamonn will join the Chesnara plc Nomination & Governance Committee, Audit & Risk Committee and Remuneration Committee as well as becoming a NonExecutive Director on the Board and Audit & Risk Committee of Countrywide Assured plc.

 

Eamonn has extensive operational experience in financial services in roles with Royal Insurance and Charterhouse/ING Barings. He also brings executive and markets experience from Shore Capital Markets where he was a Director and co-founder, as well as Non-executive experience from AJ Bell, Randall & Quilter and previously at JLT. Eamonn is a Fellow of the Institute of Actuaries.

 

Chairman Luke Savage commented:

'David, with his wealth of experience and knowledge of the Group, will be sorely missed at the Chesnara plc Board table, but I am very pleased that he will Chair our UK business whilst also continuing to Chair our Swedish business Movestic Livförsäkring AB.

 

'I am also delighted to announce the appointment, of Eamonn who will bring valuable experience, insight and skills which will be of significant benefit to the Group.'

 

There is no further information relating to Eamonn which would require disclosure under 9.6.13R of the Listing Rules.

 

 

For further information, please contact:

 

Roddy Watt

Director, Capital Markets

FWD

Forward thinking communications

 

T - 07714 770 493

E - roddy.watt@fwdconsulting.co.uk 

 

 

Notes to Editors

Chesnara is a life and pensions company listed on the London Stock Exchange. It administers over one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

 

Following a three pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 15 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFMMMTMTBJBFM
Date   Source Headline
13th May 20251:00 pmRNSSenior Independent Director Appointment
13th May 202512:44 pmRNSAGM Statement
1st May 20257:00 amRNSTotal Voting Rights
25th Apr 20257:00 amRNSBlock listing Interim Review
24th Apr 20257:00 amRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSNotice of AGM
7th Apr 202512:30 pmRNSApplication for Block Listing - Replacement
7th Apr 202512:09 pmRNSDirector/PDMR Shareholding
4th Apr 202512:00 pmRNSApplication for Block Listing
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Mar 20252:45 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSFinal Results
10th Mar 20251:41 pmRNSNotice of Results (Replacement)
10th Mar 20257:00 amRNSNotice of Results
30th Jan 20259:07 amRNSDirector/PDMR Shareholding
29th Jan 20257:00 amRNSDirectorate Changes
23rd Dec 20247:00 amRNSAcquisition
12th Dec 202412:00 pmRNSDirector/PDMR Shareholding
22nd Nov 20241:55 pmRNSDirector/PDMR Shareholding
14th Nov 20242:06 pmRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
25th Oct 20247:00 amRNSBlock listing Interim Review
11th Sep 20247:00 amRNSDirector/PDMR Shareholding
10th Sep 20247:00 amRNSHalf-year Report
12th Aug 20249:00 amRNSNotice of Half Year Results
1st Aug 20247:00 amRNSDirector/PDMR Shareholding
18th Jul 20249:00 amRNSExternal Directorship
10th Jul 20249:00 amRNSHolding(s) in Company
7th Jun 202411:28 amRNSDirector/PDMR Shareholding
6th Jun 20243:30 pmEQSHardman Talks Video | Chesnara plc (CSN) Management Presentation and Q&A
16th May 20247:00 amRNSDirector/PDMR Shareholding
14th May 20242:15 pmRNSAGM Statement
9th May 20242:04 pmEQSQ&A on Chesnara plc (CSN): Growth and stability insights
30th Apr 20244:45 pmRNSDirector/PDMR Shareholding
26th Apr 20244:57 pmRNSDirector/PDMR Shareholding
25th Apr 202410:00 amRNSBlock listing Interim Review
17th Apr 202410:00 amRNSNotice of AGM
16th Apr 20241:00 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSDirectorate Change
11th Apr 202410:23 amEQSHardman & Co Research on Chesnara plc (CSN): Good 2023 results set platform for future progress
9th Apr 20244:58 pmRNSDirectorate Change
4th Apr 20247:00 amRNSDirector/PDMR Shareholding
3rd Apr 20241:33 pmRNSDirector/PDMR Shareholding
28th Mar 202412:00 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSFinal Results
21st Mar 20247:45 amRNSDirector Declaration
14th Mar 202411:15 amRNSNotice of Results
29th Dec 202311:55 amRNSTotal Voting Rights
29th Dec 202311:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.